These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 1315543)

  • 1. Characterization of the thromboxane receptor mediating prostacyclin release from cultured endothelial cells.
    Hunt JA; Merritt JE; MacDermot J; Keen M
    Biochem Pharmacol; 1992 Apr; 43(8):1747-52. PubMed ID: 1315543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effect of pH on thromboxane A2/prostaglandin H2 receptor agonist and antagonist binding in human platelets.
    Mayeux PR; Morinelli TA; Williams TC; Hazard ES; Mais DE; Oatis JE; Baron DA; Halushka PV
    J Biol Chem; 1991 Jul; 266(21):13752-8. PubMed ID: 1830308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 7-[(1R,2S,3S,5R)-6,6-dimethyl-3-(4- iodobenzenesulfonylamino)bicyclo[3.1.1]hept-2-yl]-5(Z)-heptenoic acid: a novel high-affinity radiolabeled antagonist for platelet thromboxane A2/prostaglandin H2 receptors.
    Naka M; Mais DE; Morinelli TA; Hamanaka N; Oatis JE; Halushka PV
    J Pharmacol Exp Ther; 1992 Aug; 262(2):632-7. PubMed ID: 1386885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet and vascular thromboxane A2/prostaglandin H2 receptors. Evidence for different subclasses in the rat.
    Masuda A; Mais DE; Oatis JE; Halushka PV
    Biochem Pharmacol; 1991 Jul; 42(3):537-44. PubMed ID: 1830482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Labeling of human platelet plasma membrane thromboxane A2/prostaglandin H2 receptors using SQB, a novel biotinylated receptor probe.
    Komiotis D; Wencel-Drake JD; Dieter JP; Lim CT; Le Breton GC
    Biochem Pharmacol; 1996 Sep; 52(5):763-70. PubMed ID: 8765474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Homologous desensitization of human platelet thromboxane A2/prostaglandin H2 receptors.
    Okwu AK; Ullian ME; Halushka PV
    J Pharmacol Exp Ther; 1992 Jul; 262(1):238-45. PubMed ID: 1378092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism for homologous downregulation of thromboxane A2 receptors in cultured human chronic myelogenous leukemia (K562) cells.
    Dorn GW
    J Pharmacol Exp Ther; 1991 Oct; 259(1):228-34. PubMed ID: 1833525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of functional PGH2/TxA2 receptors on human endothelial cells.
    Kent KC; Collins LJ; Schwerin FT; Raychowdhury MK; Ware JA
    Circ Res; 1993 May; 72(5):958-65. PubMed ID: 8477529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding of a thromboxane A2/prostaglandin H2 receptor antagonist to washed human platelets.
    Mais DE; Burch RM; Saussy DL; Kochel PJ; Halushka PV
    J Pharmacol Exp Ther; 1985 Dec; 235(3):729-34. PubMed ID: 3001275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dissociation of the contractile and hypertrophic effects of vasoconstrictor prostanoids in vascular smooth muscle.
    Dorn GW; Becker MW; Davis MG
    J Biol Chem; 1992 Dec; 267(34):24897-905. PubMed ID: 1447225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding of an 125I-labeled thromboxane A2/prostaglandin H2 receptor antagonist to washed canine platelets.
    Mais DE; Kochel PJ; Saussy DL; Halushka PV
    Mol Pharmacol; 1985 Aug; 28(2):163-9. PubMed ID: 2991736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decrease in agonist affinity for human platelet thromboxane A2/prostaglandin H2 receptors induced by a platelet-derived supernatant.
    Dorn GW; Burch RM; Kochel PJ; Mais DE; Halushka PV
    Biochem Pharmacol; 1987 Jun; 36(12):1913-7. PubMed ID: 2954555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in activities of thromboxane A2 receptor antagonists in smooth muscle cells.
    Miki I; Kase H; Ishii A
    Eur J Pharmacol; 1992 Oct; 227(2):199-204. PubMed ID: 1426029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of a thromboxane A2/prostaglandin H2 receptor in guinea pig lung membranes using a radioiodinated thromboxane mimetic.
    Saussy DL; Mais DE; Dubé GP; Magee DE; Brune KA; Kurtz WL; Williams CM
    Mol Pharmacol; 1991 Jan; 39(1):72-8. PubMed ID: 1824791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacologic characterization of human and canine thromboxane A2/prostaglandin H2 receptors in platelets and blood vessels: evidence for different receptors.
    Mais DE; Saussy DL; Chaikhouni A; Kochel PJ; Knapp DR; Hamanaka N; Halushka PV
    J Pharmacol Exp Ther; 1985 May; 233(2):418-24. PubMed ID: 2987481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ONO NT-126 is a potent and selective thromboxane A2 antagonist in human astrocytoma cells.
    Nakahata N; Sato K; Abe MT; Nakanishi H
    Eur J Pharmacol; 1990 Aug; 184(2-3):233-8. PubMed ID: 1964127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interspecies differences in thromboxane receptors: studies with thromboxane receptor antagonists in rat and guinea pig smooth muscles.
    Ogletree ML; Allen GT
    J Pharmacol Exp Ther; 1992 Feb; 260(2):789-94. PubMed ID: 1531361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Agonist-induced phosphorylation of human platelet TXA2/PGH2 receptors.
    Okwu AK; Mais DE; Halushka PV
    Biochim Biophys Acta; 1994 Mar; 1221(1):83-8. PubMed ID: 8130280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Desensitization of platelet thromboxane A2/prostaglandin H2 receptors by the mimetic U46619.
    Liel N; Mais DE; Halushka PV
    J Pharmacol Exp Ther; 1988 Dec; 247(3):1133-8. PubMed ID: 2974487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antagonistic actions of S-145 on vascular and platelet thromboxane A2 receptors.
    Mihara S; Hara S; Ueda M; Ide M; Fujimoto M
    Eur J Pharmacol; 1989 Nov; 171(2-3):179-87. PubMed ID: 2533558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.